


Anti-Fragility Health Clinic in Anaheim, California, operates under the medical direction of Dr. Daniel Johnson, MD, delivering peptide-based therapies and hormone optimization protocols designed for metabolic health and sustainable weight management. The clinic's name reflects a core philosophy: building physiological resilience rather than merely treating symptoms. Dr. Johnson integrates peptide therapy with comprehensive hormone replacement and nutritional counseling to address the underlying mechanisms of weight gain, metabolic dysfunction, and age-related decline. Patients in Orange County seeking medical weight loss and hormone balance benefit from the clinic's partnership with a compounding pharmacy, ensuring access to pharmaceutical-grade peptides and customized formulations tailored to individual treatment plans.
The clinic's peptide and GLP-1 agonist protocols center on three primary agents: NAD+ for cellular energy and mitochondrial function, semaglutide for appetite regulation and glycemic control, and tirzepatide, a dual GIP/GLP-1 receptor agonist offering enhanced weight loss outcomes compared to single-pathway medications. Dr. Johnson prescribes these peptides within structured programs that include baseline metabolic testing, body composition analysis, and ongoing monitoring of thyroid function, insulin sensitivity, and lipid panels. Semaglutide and tirzepatide are administered via subcutaneous injection on weekly schedules, with dosing titrated based on patient tolerance and weight loss velocity. NAD+ therapy is delivered through intramuscular injection or sublingual formulations, supporting patients experiencing fatigue, cognitive decline, or recovery from metabolic stress. The clinic does not offer intravenous NAD+ infusions but focuses on peptide protocols that patients can self-administer at home between office visits.
Dr. Daniel Johnson completed his medical degree and brings a clinical approach that emphasizes patient education and shared decision-making. His consultations in Anaheim involve detailed discussions of peptide mechanisms, expected timelines for results, and potential side effects such as gastrointestinal symptoms common with GLP-1 agonists. Hormone replacement therapy at Anti-Fragility Health Clinic addresses testosterone deficiency in men and estrogen/progesterone imbalances in women, often in conjunction with peptide therapy to optimize body composition and energy levels. Dr. Johnson evaluates patients for contraindications to peptide use, including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2, ensuring safe prescribing practices. His nutritional counseling integrates with peptide protocols, providing macronutrient targets and meal timing strategies that enhance the metabolic effects of semaglutide and tirzepatide while preventing muscle loss during caloric restriction.
Patients at the Anaheim clinic undergo in-person consultations for initial assessments and periodic follow-ups, allowing Dr. Johnson to perform physical examinations and review laboratory results in real time. The typical patient journey begins with a comprehensive intake appointment lasting 60 to 90 minutes, during which medical history, current medications, and health goals are documented. Blood work is ordered to establish baseline hormone levels, metabolic markers, and kidney function before initiating peptide therapy. Follow-up visits occur every four to six weeks during the active weight loss phase, with adjustments made to peptide dosing or the addition of adjunctive therapies such as vitamin B12 injections or lipotropic compounds. The clinic's partnership with a compounding pharmacy enables access to peptide formulations not available through commercial channels, including custom-dosed semaglutide vials and NAD+ preparations with enhanced stability. Patients receive detailed injection training and are provided with sharps containers and refrigeration guidelines for peptide storage.
Anti-Fragility Health Clinic distinguishes itself in the Orange County market through its integration of peptide therapy with functional nutrition and hormone optimization rather than offering peptides as standalone treatments. Dr. Johnson's protocols address the hormonal and metabolic factors that contribute to treatment-resistant weight gain, including thyroid dysfunction, cortisol dysregulation, and insulin resistance. The clinic's 4.6-star rating across 45 Google reviews reflects patient experiences with the thoroughness of Dr. Johnson's consultations and the clinical outcomes achieved through peptide-based weight loss programs. Located in Anaheim, the clinic serves patients throughout Orange County who prefer in-person medical oversight for peptide therapy rather than telehealth-only models. The clinic does not accept insurance for peptide therapy or weight loss services, operating on a fee-for-service basis with transparent pricing provided during the initial consultation. Patients seeking medically supervised weight loss with semaglutide or tirzepatide, NAD+ therapy for cellular health, or bioidentical hormone replacement will find a structured, physician-led approach at Anti-Fragility Health Clinic.
Dr. Daniel Johnson· MD
Dr. Daniel Johnson, MD
Medical Director
Charles Sine, CEO
Cathy, Nutritionist
IV Therapy & Infusions
IV Drip therapy delivering nutrients with 100% bioavailability to the body
Intramuscular (IM) Shot Therapy
IM injections delivering nutrients with 100% bioavailability to the body
Biomarker Assessment
Blood test evaluating 52 nutritional components including vitamins, minerals, amino acids and fatty acids to uncover insufficiencies
Semaglutide & Tirzepatide
Weight loss peptide therapy
Hormone Replacement Therapy
Hormone optimization therapy
I-Motion EMS
Electrical muscle stimulation for weight loss
Nutrition Counseling
Personalized nutrition guidance
Comprehensive Diagnostics
Advanced diagnostic testing and biomarker assessment
MyPeptideMatch.com is an independent directory. We do not provide medical advice. Always consult a qualified healthcare provider before starting any peptide therapy.


